Abstracts tagged "Ulcerative Colitis"

Abstract Number: 1093 • 2019 ACR/ARP Annual Meeting
The US Prevalence of Inflammatory Bowel Disease and Associated Axial Pain: Data from the National Health & Nutrition Examination Survey (NHANES)
Oleg Stens¹, Charles Dillon ², Frederick W. Miller ³ and Michael Weisman ⁴, ¹Harbor-UCLA Medical Center, Torrance, CA, ²National Institutes of Health, Bethesda, MD, ³NIEHS, NIH, Bethesda, MD, ⁴David Geffen School of Medicine at UCLA, Los Angeles, CA
Background/Purpose: Associations between ulcerative colitis (UC) and Crohn’s disease, known together as inflammatory bowel disease (IBD), with axial pain, inflammatory back pain (IBP) and spondyloarthritis…
Abstract Number: 367 • 2018 ACR/ARHP Annual Meeting
Incidence of Inflammatory Bowel Disease (IBD) Among Patients (Pts) with Other Chronic Inflammatory Diseases (CID) Treated with Interleukin-17a (IL-17a) or Phosphodiesterase 4 (PDE4) Inhibitors
Bruno Emond¹, Lorie A. Ellis², Soumya D Chakravarty³, Martin Ladouceur¹ and Patrick Lefebvre¹, ¹Analysis Group, Inc., Montréal, QC, Canada, ²Janssen Scientific Affairs, LLC, Horsham, PA, ³Janssen Scientific Affairs, LLC/Drexel University School of Medicine, Horsham/Phila, PA
Background/Purpose: IBD is often associated with other CID, such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and psoriasis (PsO). Newer biologic agents…
Abstract Number: 1866 • 2018 ACR/ARHP Annual Meeting
Incidence of Inflammatory Bowel Disease Among Patients Treated with Ixekizumab: An Update on Adjudicated Data from an Integrated Database of Patients with Psoriasis and Psoriatic Arthritis
Mark C. Genovese¹, Jean-Frederic Colombel², Amanda M. Gellett³, Wen Xu³ and Dana Hardin³, ¹Department of Medicine, Stanford University, Palo Alto, CA, ²Department of Gastroenterology, The Mount Sinai Hospital, New York, NY, ³Eli Lilly and Company, Indianapolis, IN
Background/Purpose: Increased incidence of IBD, such as Crohn’s disease (CD) and ulcerative colitis (UC), has been observed in patients (pts) with PsA or plaque psoriasis…
Abstract Number: 962 • 2016 ACR/ARHP Annual Meeting
No Increased Risk of Inflammatory Bowel Disease Among Secukinumab-Treated Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis: Data from 14 Phase 2 and Phase 3 Clinical Studies
Atul A. Deodhar¹, Stefan Schreiber², Kunal Gandhi³, Todd Fox⁴, Corine Gaillez⁴ and Chetan Karyekar³, ¹Oregon Health & Science University, Portland, OR, ²Christian-Albrechts-Universität Kiel, Kiel, Germany, ³Novartis Pharmaceuticals Corporation, East Hanover, NJ, ⁴Novartis Pharma AG, Basel, Switzerland
Background/Purpose: Secukinumab, a fully human anti–interleukin-17A monoclonal antibody, has been evaluated and approved for the treatment of moderate to severe psoriasis, active psoriatic arthritis (PsA)…
Abstract Number: 2142 • 2015 ACR/ARHP Annual Meeting
Comparison of Interferon-y Release Assay Versus Tuberculin Skin Test in the Golimumab UC and the Golimumab SC Rheumatology (RA, PsA, and AS) Clinical Study Programs
Elizabeth C. Hsia^1,2, Neil Schluger³, John J. Cush⁴, Eric L. Matteson⁵, Stephen Xu¹, William Sandborn⁶, Paul Rutgeerts⁷ and Colleen Marano¹, ¹Janssen Research & Development, LLC, Spring House, PA, ²University of Pennsylvania, Philadelphia, PA, ³Columbia U College of Physicians & Surgeons, New York, NY, ⁴Baylor Research Institute, Dallas, TX, ⁵Division of Rheumatology, Department of Internal Medicine and Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ⁶Inflammatory Bowel Disease Center, Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, California, La Jolla, CA, ⁷University Hospital Gasthuisberg, Leuven, Belgium
Background/Purpose: Interferon-ƴ release assays (IGRAs) offer the possibility of an improved method to detect TB infections in pts with autoimmune disorders. Compare results of…
Abstract Number: 2209 • 2014 ACR/ARHP Annual Meeting
Novel Biomarkers of Extracellular Matrix Remodeling in Inflammatory Bowel Disease: Different Patterns of Gut Injury in UC and CD
Joachim Høg Mortensen¹, Line Elberg Godskesen², Michael Dam Jensen², Lone Gabriels Klinge², Jens Kjeldsen², Aleksander Krag², Morten Karsdal³ and Anne C. Bay-Jensen⁴, ¹Cartilage Biomarkers and Research, Nordic Bioscience, Købehavn, Denmark, ²Odense University Hospital, Odense, Denmark, ³Research & Development, Nordic Bioscience, Biomarkers and Research, Herlev, Denmark, ⁴Cartilage Biomarkers and Research, Nordic Bioscience, Herlev, Denmark
Background/Purpose: About 10 % of patients with IBD have symptoms that match both Crohn's disease (CD) and ulcerative colitis (UC), termed inflammatory bowel disease unclassified…
Abstract Number: 805 • 2014 ACR/ARHP Annual Meeting
Takayasu Arteritis and Ulcerative Colitis –High Concurrence Ratio and Genetic Overlap
Chikashi Terao¹, Takayoshi Matsumura², Hajime Yoshifuji³, Yohei Kirino⁴, Yasuhiro Maejima⁵, Yoshikazu Nakaoka⁶, Meiko Takahashi¹, Eisuke Amiya², Natsuko Tamura⁵, Toshiki Nakajima³, Tomoki Origuchi⁷, Tetsuya Horita⁸, Mitsuru Matsukura², Yuta Kochi², Akiyoshi Ogimoto⁹, Motohisa Yamamoto¹⁰, Hiroki Takahashi¹¹, Shingo Nakayamada¹², Kazuyoshi Saito¹², Yoko Wada¹³, Ichiei Narita¹³, Yasushi Kawaguchi¹⁴, Hisashi Yamanaka¹⁴, Koichiro Ohmura³, Tatsuya Atsumi⁸, Kazuo Tanemoto¹⁵, Tetsuro Miyata², Masataka Kuwana¹⁶, Issei Komuro², Yasuharu Tabara¹, Atsuhisa Ueda¹⁷, Mitsuaki Isobe¹⁸, Tsuneyo Mimori³ and Fumihiko Matsuda¹, ¹Kyoto University Graduate School of Medicine, Kyoto, Japan, ²Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, ³Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan, ⁴Yokohama City University Graduate School of Medicine, Yokohama, Japan, ⁵Tokyo Medical and Dental University, Tokyo, Japan, ⁶Osaka University Graduate School of Medicine, Osaka, Japan, ⁷Department of Health Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, ⁸Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan, ⁹Ehime University Graduate School of Medicine, Ehime, Japan, ¹⁰Sapporo Medical University School of Medicine, Sapporo, Japan, ¹¹First Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan, ¹²The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, ¹³Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, ¹⁴Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ¹⁵Kawasaki Medical School, Kurashiki, Japan, ¹⁶Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, ¹⁷Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan, ¹⁸Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan
Background/Purpose . Takayasu arteritis (TAK) is a systemic vasculitis affecting large arteries and large branches of the aorta. Ulcerative colitis (UC) is a prevalent autoimmune…
Abstract Number: 2002 • 2013 ACR/ARHP Annual Meeting
Prophylactic Duration and Serum Uric Acid Level Are Associated With Gout Flare During Urate Lowering Treatment
Hyo-Jin Choi¹, Chan Hee Lee², Sang Tae Choi³, Jung-Soo Song³, Hyoun-Ah Kim⁴, Chang-Hee Suh⁵, Hoyeon Joo⁶, Ki Chul Shin⁷ and Hanjoo Baek¹, ¹Rheumatology, Gachon University Gil Hospital, Incheon, South Korea, ²Div Rheum Dept of Intl Med, NHIC Ilsan Hospital, Goyang-si, South Korea, ³Rheumatology, Chung-Ang University College of Medicine, Seoul, South Korea, ⁴Department of Rheumatology, Ajou University School of Medicine, Suwon, South Korea, ⁵Department of Rheumatology, Ajou University Hospital, Suwon, South Korea, ⁶Division of Rheumatology, Department of Internal Medicine, Inha University Hospital, Incheon, South Korea, ⁷Rheumatology, Seoul National University College of Medicine, Seoul, South Korea
Background/Purpose: To evaluate the clinical factors on gout flare during urate lowering treatment Methods: We retrospectively examined data derived from 228 patients who had been treated…